Multiple Ascending Dose Study to Assess the Pharmacokinetics, Safety, and Tolerability of Orally Administered SYN 020
Clinical trial NCT05045833 · COMPLETED
Trial details
- NCT number
- NCT05045833
- Sponsor
- Theriva Biologics, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-18
- Primary completion
- 2022-02-22
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.